ANI Pharma Inc (ANIP)

$68.29 -1.07 (-1.54%)
Market Cap 1.46B
Revenue (ttm) 614.38M
Net Income (ttm) -18.52M
EPS (ttm) N/A
PE Ratio 16.49
Forward PE 12.83
Profit Margin -3.01%
Debt to Equity Ratio 0.74
Volume 457,300
Avg Vol 281,884
Day's Range N/A - N/A
Shares Out 21.77M
Stochastic %K 99%
Beta 0.62
Analysts Strong Sell
Price Target $81.50

Latest News on ANIP

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Mar 31, 2025, 4:30 PM EDT - 3 days ago

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Mar 19, 2025, 6:50 AM EDT - 15 days ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

Mar 18, 2025, 6:50 AM EDT - 16 days ago

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Mar 14, 2025, 6:50 AM EDT - 20 days ago

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

Mar 3, 2025, 4:30 PM EST - 4 weeks ago

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

ANI Pharmaceuticals, Inc. (ANIP) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 5:45 PM EST - 4 weeks ago

ANI Pharmaceuticals, Inc. (ANIP) Q4 2024 Earnings Call Transcript

ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast

Feb 28, 2025, 10:37 AM EST - 4 weeks ago

ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

Feb 28, 2025, 6:50 AM EST - 4 weeks ago

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March

Feb 19, 2025, 4:30 PM EST - 6 weeks ago

ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

Feb 18, 2025, 4:05 PM EST - 6 weeks ago

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

ANI Pharmaceuticals: More Than Just A Generics Company

Feb 11, 2025, 9:08 AM EST - 7 weeks ago

ANI Pharmaceuticals: More Than Just A Generics Company

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

Jan 28, 2025, 4:30 PM EST - 2 months ago

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

Alcami Announces CEO Transition

Jan 13, 2025, 11:12 AM EST - 2 months ago

Alcami Announces CEO Transition

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

Jan 13, 2025, 6:50 AM EST - 2 months ago

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

Jan 2, 2025, 6:50 AM EST - 3 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 4:05 PM EST - 3 months ago

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

Nov 26, 2024, 4:30 PM EST - 4 months ago

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 11:05 PM EST - 5 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

Nov 8, 2024, 6:50 AM EST - 5 months ago

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

Nov 4, 2024, 4:30 PM EST - 5 months ago

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

Oct 30, 2024, 5:00 PM EDT - 5 months ago

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

Oct 25, 2024, 6:50 AM EDT - 5 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

Oct 24, 2024, 6:50 AM EDT - 5 months ago

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential

Oct 11, 2024, 1:40 PM EDT - 6 months ago

ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

Oct 11, 2024, 4:01 AM EDT - 6 months ago

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

Sep 26, 2024, 6:50 AM EDT - 6 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

Sep 16, 2024, 8:53 AM EDT - 7 months ago

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

Sep 16, 2024, 6:50 AM EDT - 7 months ago

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

Sep 13, 2024, 6:50 AM EDT - 7 months ago

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

Sep 11, 2024, 6:50 AM EDT - 7 months ago

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

Sep 10, 2024, 2:09 PM EDT - 7 months ago

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement

Sep 10, 2024, 9:00 AM EDT - 7 months ago

Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement

ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

Aug 19, 2024, 6:20 PM EDT - 8 months ago

ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers' Option to Purchase Additional Notes

Aug 13, 2024, 4:05 PM EDT - 8 months ago

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers' Option to Purchase Additional Notes

ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 12:40 PM EDT - 8 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

Aug 7, 2024, 9:44 PM EDT - 8 months ago

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

Aug 7, 2024, 7:00 AM EDT - 8 months ago

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

Aug 6, 2024, 6:50 AM EDT - 8 months ago

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028

Aug 2, 2024, 1:06 AM EDT - 8 months ago

ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

Jul 15, 2024, 7:00 AM EDT - 9 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

Jul 2, 2024, 7:00 AM EDT - 9 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

ANI Pharmaceuticals' CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

Jun 25, 2024, 7:00 AM EDT - 10 months ago

ANI Pharmaceuticals' CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

Jun 24, 2024, 6:50 AM EDT - 10 months ago

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked

Jun 10, 2024, 1:50 AM EDT - 10 months ago

ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

May 29, 2024, 4:30 PM EDT - 11 months ago

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

May 20, 2024, 6:50 AM EDT - 11 months ago

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript

May 10, 2024, 2:14 PM EDT - 11 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

May 10, 2024, 6:50 AM EDT - 11 months ago

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance